Kirin Cashes Out of Amgen Drug Joint Venture for $780M Post author:Sam Post published:October 30, 2017 Post category:BioPharma Amgen and Kirin have decided to dissolve their joint venture, Kirin-Amgen. Source: BioSpace You Might Also Like North Carolina Sues Insys Accused of Bribing Doctors to Prescribe Powerful Opioid Spray December 21, 2017 Martin Shkreli Ordered to Forfeit $7.36 Million in Assets Ahead of Sentencing March 5, 2018 Glytec LLC Release: New Research Further Validates Benefits Of Personalized Diabetes Therapy Management Across The Continuum Of Care February 15, 2017
North Carolina Sues Insys Accused of Bribing Doctors to Prescribe Powerful Opioid Spray December 21, 2017
Glytec LLC Release: New Research Further Validates Benefits Of Personalized Diabetes Therapy Management Across The Continuum Of Care February 15, 2017
